Search
for
Sort by
Research 30 of 35
- A model for the turnover of dihydrotestosterone in the presence of the irreversible 5α-reductase inhibitors GI198745 and finasteride
- Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5α-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat 3 3Abbreviations: r5AR1, rat 5α-reductase 1; r5AR2, rat 5α-reductase 2; and DHT, dihydrotestosterone.
- Androgenetic Alopecia: Overview
- Dihydrotestosterone and the Concept of 5α–Reductase Inhibition in Human Benign Prostatic Hyperplasia
- Novel agents for the treatment of alopecia
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Hormonal Therapy for Acne
- Idiopathic Hirsutism*
- Effects of PNU157706, a Dual 5α-Reductase Inhibitor, on Rat Epididymal Sperm Maturation and Fertility1
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- ANDROGENETIC ALOPECIA
- Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5‐Alpha Reductase Inhibitor Therapy
- Estimating the Contribution of the Prostate to Blood Dihydrotestosterone
- Mechanism of Salutary Effects of Finasteride on Post-traumatic Immune/Inflammatory Response
- Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
- Beneficial effects of finasteride on hepatic and pulmonary immune response after trauma hemorrhage in mice
- Pharmacologically altered Androgens, Brain Activation and Response Inhibition in a Stop-Signal Task in Male Heavy Drinkers
- A concise review- Development of an analytical method and validation of dutasteride
- Medical Management Options for Hair Loss
- Pharmacodynamic modeling of finasteride, a 5 alpha-reductase inhibitor.
- 5 alpha-reductase inhibition by a new synthetic steroid (PM-9) in cultures of Penicillium crustosum.
- A population pharmacokinetic model for individualized regimens of finasteride according to CYP3A5 genotype and liver function
- 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder
- Dutasteride reduces alcohol’s sedative effects in men in a human laboratory setting and reduces drinking in the natural environment
- SRD5A2 and emerging therapies in androgen-driven disorders
- Simultaneous Target-Mediated Drug Disposition-Pharmacodynamic (TMDD-PD) Modeling of Finasteride and Dutasteride: Impact of Target Binding and Turnover on Non-linear Pharmacokinetics
- Pharmacological Role and Clinical Applications of 5α-Reductase Inhibitors-Review Article for Pharmacists and Healthcare Professionals